PHARMACOKINETICS OF AN ORAL SOLUTION OF THE MICROEMULSION FORMULATION OF CYCLOSPORINE IN MAINTENANCE PEDIATRIC LIVER TRANSPLANT RECIPIENTS1

Abstract

This study shows increased bioavailability in all patients converted to CsA-ME, with the greatest increase seen in patients with the lowest initial cyclosporine bioavailability. The tolerability was similar between the two formulations during this study.